Surprisingly, we found that the Mtmr2 knockout mice, a model of CMT4B1, have a defect in nerve regeneration and that niacin-based treatment is not detrimental to nerve regeneration. The gene discussed is MTMR2; the disease is Charcot-Marie-Tooth disease type 4B1.